Association of autism severity with a monoamine oxidase A functional polymorphism

Clinical Genetics

Volumn 64, Issue 3, 2003, Pages 190-197

  Cohen, Ira L ^a   Liu, X ^b   Schutz, C ^b   White, B N ^d   Jenkins, E C ^a   Brown, W T ^a   Holden, J J A ^b,c  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c Onganada   (Canada)

^d TRENT UNIVERSITY   (Canada)

Author keywords

Autism; Autism severity; Genetic heterogeneity; IQ; MAOA; uVNTR

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ALLELE; ARTICLE; AUTISM; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA MODIFICATION; FOLLOW UP; GENE ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; INTELLIGENCE QUOTIENT; INTERVIEW; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOLOGIC ASSESSMENT; SEROTONINERGIC SYSTEM; TIME; VARIABLE NUMBER OF TANDEM REPEAT;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ALLELES; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; COGNITION; FEMALE; FOLLOW-UP STUDIES; GENETICS, BEHAVIORAL; GENOTYPE; HUMANS; INTELLIGENCE TESTS; LANGUAGE TESTS; LONGITUDINAL STUDIES; MALE; MINISATELLITE REPEATS; MONOAMINE OXIDASE; PROMOTER REGIONS (GENETICS); PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 0041411177     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00115.x     Document Type: Article

References (41)

1. Azmitia EC. Neuronal instability: implications for Rett's syndrome. Brain Dev 2001: 23 (Suppl. 1): S1-S10.
2. Anderson LT, Campbell M, Grega DM, Perry R, Small AM, Green WH. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. Am J Psychiatry 1984: 141: 1195-1202.
3. Campbell M, Anderson LT, Meier M et al. A comparison of haloperidol and behavior therapy and their interaction in autistic children. J Am Acad Child Psychiatry 1978: 17: 640-655.
4. Campbell M, Anderson LT, Cohen IL et al. Haloperidol in autistic children: effects on learning, behavior and abnormal involuntary movements. Psychopharmacol Bull 1982: 18: 110-112.
5. Cohen IL, Campbell M, Posner D, Triebel D, Small AM, Anderson LT. A study of haloperidol in young autistic children: a within-subjects design using objective rating scales. Psychopharmacol Bull 1980: 16: 63-65.
6. Posey DJ, Walsh KH, Wilson GA, McDougle CJ. Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 1999: 9: 273-276.
7. Anderson GM, Freedman DX, Cohen DJ et al. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987: 28: 885-900.
8. Cook EH Jr, Leventhal BL, Heller W, Metz J, Wainwright M, Freedman DX. Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence. J Neuropsychiatry Clin Neurosci 1990: 2: 268-274.
9. Kuperman S, Beeghly J, Burns T, Tsai L. Association of serotonin concentration to behavior and IQ in autistic children. J Autism Dev Disord 1987: 17: 133-140.
10. Chugani DC, Muzik O, Behen M et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999: 45: 287-295.
11. Narita N, Kato M, Tazoe M, Miyazaki K, Narita M, Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr Res 2002: 52: 576-579.
12. Lassig JP, Vachirasomtoon K, Hartzell K et al. Physical mapping of the serotonin 5-HT (7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder. Am J Med Genet 1999: 88: 472-475.
13. Betancur C, Corbex M, Spielewoy C et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry 2002: 7: 67-71.
14. Zhong N, Ye L, Ju W, Brown WT, Tsiouris J, Cohen I. 5-HTTLPR variants not associated with autistic spectrum disorders. Neurogenetics 1999: 2: 129-131.
15. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997: 6: 2233-2238.
16. Yirmiya N, Pilowsky T, Nemanov L et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet 2001: 105: 381-386.
17. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998: 103: 273-279.
18. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993: 262: 578-580.
19. Kim JJ, Shih JC, Chen K et al. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc Natl Acad Sci USA 1997: 94: 5929-5933.
20. Cases O, Lebrand C, Giros B et al. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J Neurosci 1998: 18: 6914-6927.
21. Denney RM, Koch H, Craig IW. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet 1999: 105: 542-551.
22. Schmidt L, Sander T, Kuhn S et al. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressed alcoholics. J Neural Transm 2000: 107: 681-689.
23. Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 2000: 95: 9-23.
24. Caspi A, McClay J, Moffitt TE et al. Role of genotype in the cycle of violence in maltreated children. Science 2002: 297: 851-854.
25. Griffiths R. The Abilities of Young Children: a Comprehensive System of Mental Measurement for the First Eight Years of Life, revised edn. Bucks, UK: A.R.I.C.D. The Test Agency Limited, 1984.
26. Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales. Interview Edition. Survey Form Manual. Circle Pines, MN: American Guidance, 1984.
27. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994: 24: 659-685.
28. Lord C, Risi S, Lambrecht L et al. The Autism Diagnostic Observation Schedule-Generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000: 30: 205-223.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders IV. Washington, DC: American Psychiatric Association 1994.
30. Zimmerman IL, Steiner VG, Pond RE. Preschool Language Scale 3. San Antonio, TX: The Psychological Corporation, 1992.
31. Cohen IL, Schmidt-Lackner S, Romanczyk R, Sudhalter V. The PDD Behavior Inventory: a rating scale for assessing response to intervention in children with PDD. J Autism Dev Disord 2003: 33: 31-45.
32. Cohen IL. Criterion-related validity of the PDD Behavior Inventory. J Autism Dev Disord 2003: 33: 47-53.
33. Spiker D, Lotspeich L, Dimiceli S, Szatmari P, Myers RM, Risch N. Birth order effects on nonverbal IQ scores in autism multiplex families. J Autism Dev Disord 2001: 31: 449-460.
34. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein R. Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet 2002: 114: 284-287.
35. Buxbaum JD, Silverman JM, Smith CJ et al. Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet 2001: 68: 1514-1520.
36. Cohen IL, Fisch GS, Sudhalter V et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard 1988: 92: 436-446.
37. Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002: 13: 1195-1198.
38. Schulze TG, Muller DJ, Krauss H et al. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 2000: 96: 801-803.
39. DeLong GR, Dwyer JT. Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective disease. J Autism Dev Disord 1988: 18: 593-600.
40. DeLong GR. Autism: new data suggest a new hypothesis. Neurology 1999: 52: 911-916.
41. Tordjman S, Gutknecht L, Carlier M et al. Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 2001: 6: 434-439.